Lighthouse Instruments Announces GMP License

Amsterdam, February 2025 – Lighthouse Instruments is proud to announce that its Amsterdam Analytical Service Laboratory has officially been granted a Good Manufacturing Practice (GMP) license as of January 1, 2025. 

This achievement enables Lighthouse Instruments to provide GMP-compliant Container Closure Integrity (CCI) testing for commercial and clinical batches, supporting both batch release and stability studies.

Over the years, we have been a trusted partner in delivering advanced CCI testing solutions, including the implementation of validated methods using headspace analysis. Our collaboration with customers has enabled the successful integration of FMS-Headspace Analyzers into their quality control processes, ensuring the integrity and safety of their products.

With this GMP license, Lighthouse Instruments is expanding its services to offer robust, compliant, and reliable CCI testing as part of routine quality assurance. To further support our customers, we are pleased to offer the option of serving as a back-up CCI testing laboratory for routine GMP testing needs.

Why Choose Us?

• Expertise: Decades of experience in headspace analysis and CCI testing.
• Regulatory Confidence: GMP-licensed services designed to meet stringent industry standards.
• Tailored Support: Flexible testing options, from routine testing to back-up lab services.

Would you like reliable support with your CCI testing? Contact our team today—we would like to discuss your needs.

About Lighthouse

Lighthouse Instruments, with corporate headquarters located in Charlottesville, Virginia, and European headquarters in Amsterdam, is a leading global supplier of laser test and measurement systems for the pharmaceutical, biopharmaceutical and contract manufacturing industries. Its operations are divided into three business units: Measurement Services, Laboratory Instruments, and Automation.